J M Kovarik1, A Korn, L Chodoff. Show Affiliations » 1. Novartis Pharmaceuticals, Basel, Switzerland.
Abstract
Entities: Chemical Species
Mesh: See more » AdolescentAntibodies, Monoclonal/therapeutic useAntigens, CD/bloodAntigens, CD/immunologyBasiliximabChildChild, PreschoolCyclosporine/bloodCyclosporine/therapeutic useDose-Response Relationship, DrugEnzyme-Linked Immunosorbent AssayHumansImmunosuppressive Agents/therapeutic useInfantKidney Transplantation/immunologyKidney Transplantation/physiologyPrednisone/therapeutic useReceptors, Interleukin-2/bloodReceptors, Interleukin-2/immunologyRecombinant Fusion ProteinsTime Factors
Substances: See more » Antibodies, MonoclonalAntigens, CDImmunosuppressive AgentsReceptors, Interleukin-2Recombinant Fusion ProteinsCyclosporineBasiliximabPrednisone
Year: 2001 PMID: 11750361 DOI: 10.1016/s0041-1345(01)02350-8
Source DB: PubMed Journal: Transplant Proc ISSN: 0041-1345 Impact factor: 1.066